
Ubrelvy Coupons & Savings Card – Discount Prices from $1072.49
My prescription
Edit
100MG, Ubrelvy (10 Tablets)
Select pharmacy

CVS
$1072.49
COUPON PRICE
Albertsons
$1076.47
COUPON PRICE
Walmart
$1083.39
COUPON PRICE
Walgreens
$1084.13
COUPON PRICEUbrelvy savings card
Show this card to your pharmacist
CVS
$1072.49
BIN
ID
PCN
GRP
019876
LH1861D88A
CHIPPO
LHX
Powered by
Related CGRP receptor antagonists prescriptions
More prescriptions for migraine
Related CGRP receptor antagonists prescriptions
More prescriptions for migraine
Price history for Ubrelvy
10 Tablets, 100MG
Average retail price for Ubrelvy
Average SaveHealth price for Ubrelvy
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Ubrelvy dosage forms
Dosage Quantity Price from Per unit 50MG 1 Tablet $107.25 $107.25 50MG 10 Tablets $1072.49 $107.25 100MG 10 Tablets $1072.49 $107.25 100MG 1 Tablet $107.25 $107.25 100MG 16 Tablets $1715.98 $107.25
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 50MG | 1 Tablet | $107.25 | $107.25 |
| 50MG | 10 Tablets | $1072.49 | $107.25 |
| 100MG | 10 Tablets | $1072.49 | $107.25 |
| 100MG | 1 Tablet | $107.25 | $107.25 |
| 100MG | 16 Tablets | $1715.98 | $107.25 |
Is Ubrelvy a good migraine medication?
Ubrelvy (ubrogepant) is considered an effective medication for the acute treatment of migraine attacks in adults. It works by blocking the CGRP receptor, which is involved in migraine pathophysiology. Clinical studies have shown that it can help reduce migraine pain and associated symptoms. However, its effectiveness can vary from person to person, and it is important to consult with a healthcare provider to determine if it is suitable for an individual's specific condition and medical history.
Is Ubrelvy better than Imitrex?
The effectiveness of Ubrelvy (ubrogepant) versus Imitrex (sumatriptan) can vary depending on the individual and the specific characteristics of their migraine. Ubrelvy is a newer medication that works as a CGRP receptor antagonist, while Imitrex is a triptan that works by narrowing blood vessels around the brain. Some patients may find Ubrelvy more effective or better tolerated, especially if they experience side effects with triptans or have cardiovascular concerns. Others may respond better to Imitrex. It is important for patients to consult with their healthcare provider to determine which medication is more suitable for their specific needs.
What class of drug is Ubrelvy?
Ubrelvy is classified as a calcitonin gene-related peptide (CGRP) receptor antagonist. It is used for the acute treatment of migraine with or without aura in adults.
How effective is Ubrelvy for migraines?
Ubrelvy (ubrogepant) is considered effective for the acute treatment of migraine attacks. Clinical studies have shown that it can help reduce migraine pain and other associated symptoms, such as nausea and sensitivity to light and sound, within two hours of taking the medication. Its effectiveness can vary among individuals, but many patients experience significant relief. It is important for patients to follow their healthcare provider's instructions and discuss any concerns or side effects they may experience.
What's the difference between Imitrex and Ubrelvy?
Imitrex (sumatriptan) and Ubrelvy (ubrogepant) are both medications used to treat migraines, but they work differently. Imitrex is a triptan, which works by stimulating serotonin receptors to constrict blood vessels and reduce inflammation. It is typically used to treat acute migraine attacks. Ubrelvy, on the other hand, is a CGRP receptor antagonist, which works by blocking the calcitonin gene-related peptide involved in migraine attacks. Unlike Imitrex, Ubrelvy does not cause vasoconstriction, making it a suitable option for patients who cannot use triptans due to cardiovascular concerns.
